Caitong International Asset Management’s Clearmind Medicine CMND Stock Holding History

Caitong International Asset Management’s Portfolio CMND Stock Details CMND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2	Buy	+1	New	+$6	﹤0.01%	2822

Other funds holding CMND

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Caitong International Asset Management's CMND Position: Q2 2026 in Review

Caitong International Asset Management opened a new position in Clearmind Medicine (CMND) in Q2 2026: 1 share worth $2. The stake represents ﹤0.01% of the portfolio and ranks #2822 among its holdings.

6 funds tracked by Wall St. Rank hold CMND as of Q2 2026.

Caitong International Asset Management held 1 share of Clearmind Medicine worth $2 as of Q2 2026.
Clearmind Medicine was a new Caitong International Asset Management position in Q2 2026.
Clearmind Medicine made up ﹤0.01% of Caitong International Asset Management's portfolio in Q2 2026, its #2822 holding.
6 funds tracked by Wall St. Rank held Clearmind Medicine as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.